Daishin Balance No.19 Special Purpose Acquisition Company
482690 | KO
Overview
Corporate Details
- ISIN(s):
- KR7482690005
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 중구 삼일대로 343, 중구
- Website:
- https://www.daishinspac.com/
- Sector:
- Financial and insurance activities
- Industry:
- Activities of trusts, funds and similar financial entities
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-13 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 568.2 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 479.3 KB | ||
| 2025-03-27 00:00 |
AGM Information
정기주주총회결과
|
Korean | 17.4 KB | ||
| 2025-03-19 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 17.1 KB | ||
| 2025-03-19 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 161.2 KB | ||
| 2025-03-12 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 58.7 KB | ||
| 2025-02-26 00:00 |
Major Shareholding Notification
최대주주변경
|
Korean | 11.8 KB | ||
| 2025-02-19 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 6.6 KB | ||
| 2025-02-19 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 4.7 KB | ||
| 2025-02-12 00:00 |
Major Shareholding Notification
최대주주변경
|
Korean | 19.6 KB | ||
| 2024-11-26 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 60.9 KB | ||
| 2024-11-26 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 79.7 KB | ||
| 2024-11-26 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.6 KB | ||
| 2024-11-21 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 57.9 KB | ||
| 2024-11-21 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.4 KB |
Automate Your Workflow. Get a real-time feed of all Daishin Balance No.19 Special Purpose Acquisition Company filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Daishin Balance No.19 Special Purpose Acquisition Company
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Daishin Balance No.19 Special Purpose Acquisition Company via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
A closed-end fund providing high income from a global portfolio of fixed-income securities.
United States of America
FCO
United States of America
FCO
A fund providing income and total return from global public and private infrastructure assets.
United States of America
ASGI
United States of America
ASGI
Global fund investing in real estate securities for capital appreciation and high income.
United States of America
AWP
United States of America
AWP
United States of America
SGOL
A global fund investing in healthcare, biotech, and medical device stocks for long-term growth.
United States of America
HQH
United States of America
HQH
Invests globally in healthcare stocks and bonds for income and long-term capital growth.
United States of America
THQ
United States of America
THQ
A closed-end fund seeking high income by investing in a global portfolio of credit securities.
United States of America
ACP
United States of America
ACP
A closed-end fund investing in a quality portfolio of Japanese equities for long-term growth.
United States of America
JEQ
United States of America
JEQ
A former UK investment trust focused on Japanese equities, now in voluntary winding-up.
United Kingdom
AJIT
United Kingdom
AJIT
Invests in global public and private life sciences companies for long-term capital appreciation.
United States of America
HQL
United States of America
HQL